FI894813A - Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI894813A
FI894813A FI894813A FI894813A FI894813A FI 894813 A FI894813 A FI 894813A FI 894813 A FI894813 A FI 894813A FI 894813 A FI894813 A FI 894813A FI 894813 A FI894813 A FI 894813A
Authority
FI
Finland
Prior art keywords
trimethoxybenzoyl
methoxycarbonyl
substituted
preparation
therapeutically active
Prior art date
Application number
FI894813A
Other languages
English (en)
Swedish (sv)
Other versions
FI96855B (fi
FI96855C (fi
FI894813A0 (fi
Inventor
Eduardo Pirotsky
Georges Dive
Jean-Jacques Godfroid
Francoise Heymans
Pierre Braquet
Original Assignee
Scras
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scras filed Critical Scras
Publication of FI894813A0 publication Critical patent/FI894813A0/fi
Publication of FI894813A publication Critical patent/FI894813A/fi
Publication of FI96855B publication Critical patent/FI96855B/fi
Application granted granted Critical
Publication of FI96855C publication Critical patent/FI96855C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI894813A 1988-10-11 1989-10-11 Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi FI96855C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8823776 1988-10-11
GB888823776A GB8823776D0 (en) 1988-10-11 1988-10-11 New 2-methoxycarbonyl sustituted n n'-di-(trimethoxybenzoyl)piperazines

Publications (4)

Publication Number Publication Date
FI894813A0 FI894813A0 (fi) 1989-10-11
FI894813A true FI894813A (fi) 1990-04-12
FI96855B FI96855B (fi) 1996-05-31
FI96855C FI96855C (fi) 1996-09-10

Family

ID=10644989

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894813A FI96855C (fi) 1988-10-11 1989-10-11 Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi

Country Status (33)

Country Link
US (1) US4927825A (fi)
JP (1) JPH0635451B2 (fi)
KR (1) KR970004913B1 (fi)
AR (1) AR245111A1 (fi)
AT (1) AT395422B (fi)
AU (1) AU619146B2 (fi)
BE (1) BE1003518A3 (fi)
CA (1) CA1319692C (fi)
CH (1) CH679858A5 (fi)
DE (1) DE3933882C2 (fi)
DK (1) DK500489A (fi)
DZ (1) DZ1366A1 (fi)
ES (1) ES2018404A6 (fi)
FI (1) FI96855C (fi)
FR (2) FR2637592B1 (fi)
GB (2) GB8823776D0 (fi)
GR (1) GR1000359B (fi)
HK (1) HK47492A (fi)
IE (1) IE61621B1 (fi)
IN (1) IN173326B (fi)
IT (1) IT1237087B (fi)
LU (1) LU87605A1 (fi)
MA (1) MA21651A1 (fi)
MY (1) MY105852A (fi)
NL (1) NL8902519A (fi)
NO (1) NO176179C (fi)
NZ (1) NZ230928A (fi)
OA (1) OA09429A (fi)
PT (1) PT91940B (fi)
SE (1) SE505222C2 (fi)
SG (1) SG40592G (fi)
TN (1) TNSN89109A1 (fi)
ZA (1) ZA897553B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines
GB8908587D0 (en) * 1989-04-15 1989-06-01 Scras Societe De Conseils De R New 2-substituted n,n'-ditrimethoxybenzoyl piperazines
FR2780649B1 (fr) * 1998-07-06 2001-03-09 Univ Paris Vii Denis Diderot Derives de la piperazine pour l'inhibition de la replication du virus de l'immunodeficience humaine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3318876A (en) * 1962-12-11 1967-05-09 Lepetit Spa Substituted piperazines and process for preparing same
GB1243991A (en) * 1968-06-10 1971-08-25 Ici Ltd Piperidine, morpholine and piperazine derivatives
FR2209560A1 (en) * 1972-12-07 1974-07-05 Degussa N-(Trialkoxyaroyl)-ethylenediamine derivs - useful as cardioactive medicaments, exhibit anti-ischaemic activity comparable to nitroglycerin
IT1194819B (it) * 1980-11-20 1988-09-28 Selvi & C Spa Derivati della piperazina,procedimento per la loro preparazione e relative composizioni farmaceutiche
GB8427735D0 (en) * 1984-11-02 1984-12-12 Fujisawa Pharmaceutical Co Piperazine compound
FR2581993B1 (fr) * 1985-05-14 1988-03-18 Synthelabo Derives de (benzoyl-4 piperidino)-2 phenyl-1 alcanols, leur preparation et leur application en therapeutique
US4824996A (en) * 1986-08-12 1989-04-25 American Home Products Corporation Phospholipase A2 inhibitors
IL85700A0 (en) * 1987-03-24 1988-08-31 Takeda Chemical Industries Ltd 1,4-disubstituted piperazine compounds,their production and use
GB8823775D0 (en) * 1988-10-11 1988-11-16 Scras New 2-carbonyl substituted n n'-di-(trimethoxybenzoyl)piperazines

Also Published As

Publication number Publication date
FI96855B (fi) 1996-05-31
NO894037D0 (no) 1989-10-10
NZ230928A (en) 1990-08-28
FR2637499A1 (fr) 1990-04-13
AU4268789A (en) 1990-04-26
ATA234589A (de) 1992-05-15
DE3933882A1 (de) 1990-04-19
PT91940A (pt) 1990-04-30
FI96855C (fi) 1996-09-10
MY105852A (en) 1995-01-30
GB8823776D0 (en) 1988-11-16
IN173326B (fi) 1994-04-02
ES2018404A6 (es) 1991-04-01
AT395422B (de) 1992-12-28
HK47492A (en) 1992-07-10
NL8902519A (nl) 1990-05-01
CA1319692C (en) 1993-06-29
KR970004913B1 (ko) 1997-04-08
SE505222C2 (sv) 1997-07-21
US4927825A (en) 1990-05-22
IT8921990A1 (it) 1991-04-11
GB2224027A (en) 1990-04-25
JPH02196775A (ja) 1990-08-03
BE1003518A3 (fr) 1992-04-14
GR1000359B (el) 1992-06-30
DZ1366A1 (fr) 2004-09-13
KR900006310A (ko) 1990-05-07
SE8903313D0 (sv) 1989-10-09
GB2224027B (en) 1992-01-15
IT8921990A0 (it) 1989-10-11
IE61621B1 (en) 1994-11-16
OA09429A (fr) 1992-10-15
DK500489A (da) 1990-04-12
IE893257L (en) 1990-04-11
JPH0635451B2 (ja) 1994-05-11
TNSN89109A1 (fr) 1991-02-04
DK500489D0 (da) 1989-10-10
FI894813A0 (fi) 1989-10-11
MA21651A1 (fr) 1990-07-01
NO176179C (no) 1995-02-15
FR2637499B1 (fr) 1992-06-05
SG40592G (en) 1992-06-12
LU87605A1 (fr) 1990-02-07
FR2637592A1 (fr) 1990-04-13
CH679858A5 (fi) 1992-04-30
AR245111A1 (es) 1993-12-30
PT91940B (pt) 1995-05-31
NO176179B (no) 1994-11-07
DE3933882C2 (de) 1993-10-07
GB8922854D0 (en) 1989-11-29
GR890100646A (en) 1990-11-29
IT1237087B (it) 1993-05-18
ZA897553B (en) 1990-10-31
FR2637592B1 (fr) 1992-10-23
SE8903313L (sv) 1990-04-12
NO894037L (no) 1990-04-17
AU619146B2 (en) 1992-01-16

Similar Documents

Publication Publication Date Title
FI96861C (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI890282A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 23,24-didehydro-25-hydroksikalsiferolijohdannaisten valmistamiseksi
NO164025C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-imidazolylmetyl-tetrahydrokarbazolon-derivater.
NO880182L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,2-dihydro-3h-indazol-3-on-derivater.
NO161497C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 9a-aza-9a-homoerytromycin-derivater.
NO176275C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridazinonderivater
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
FI871087A (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
NO164541C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater.
NO173503C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydroimidayo (1,4) benzodiazepin-2-tioner
NO173784C (no) Anaslogifremgangsmaate for fremstilling av terapeutisk aktive tieno-tri-azolo-diazepinderivater
NO175976C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-(1,6-dihydro-6-okso-pyridazinyl-3-oksy)-3-kromanolderivater
FI892684A (fi) Menetelmä terapeuttisesti aktiivisten 4-okso-imidatso/1,5-a/kinoksaliinijohdannaisten valmistamiseksi
FI900145A (fi) Menetelmä farmaseuttisesti käyttökelpoisten 1,1-diokso-kefem-4-karbotiolihappojohdannaisten valmistamiseksi
NO862390D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4-dihydropyridinderivater.
FI894813A (fi) Menetelmä terapeuttisesti aktiivisten 2-metoksikarbonyylisubstituoitujen N,N'-di(trimetoksibentsoyyli)piperatsiinijohdannaisten valmistamiseksi
FI894812A (fi) Menetelmä valmistaa farmakologisesti arvokkaita 2-karbonyylisubstituoituja N,N'-di(trimetoksibentsoyyli)piperatsiineja
FI93216C (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
NO860091L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 12-amino-pyridazino(4[,5[:3,4)pyrrolo(2,1-a)isokinolin-derivater.
NO913644D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive aminosyrederivater.
NO167801C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 2,2'-bi-1h-imidazolderivater.
NO893768D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 2,7-diamino-1,2,3,4-tetrahydronaftalenderivater.
FI893121A (fi) Menetelmä farmakologisesti aktiivisten 6,21-dimetyyli-19-norprogesteronijohdannaisten valmistamiseksi
FI93010B (fi) Menetelmä 1,5-bentsotiatsepiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: SOCIETE DE CONSEILS DE RECHERCHES ET D APPLICATION

MA Patent expired